英诺特2025年净利1.46亿元，同比下降40.84%

Core Viewpoint - In the 2025 performance report, Innotec (688253) experienced significant declines in both revenue and net profit, attributed to industry policy impacts and intensified competition in its main business areas [1] Group 1: Financial Performance - Innotec reported a revenue of 422 million yuan for 2025, representing a year-on-year decrease of 32.08% [1] - The company achieved a net profit attributable to shareholders of 146 million yuan, down 40.84% year-on-year [1] Group 2: Industry Context - The in vitro diagnostic industry faced challenges due to regulatory policies related to medical insurance and taxation [1] - Increased competition in the specific testing fields of respiratory and digestive pathogens further pressured the company's performance in 2025 [1]